Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2014: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2013: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
We have developed a new treatment for peripheral nerve defects: nerve lengthening method. We have applied this method in a clinical setting in 2009, clinical cases brought some new challenges. This investigation aimed at making improvement nerve lengthening method. (1) Development of automated nerve lengthening system. Continuous nerve lengthening enabled by automated system, is more efficient lengthening than intermittent manual lengthening. (2) Prevention of nerve adhesion during lengthening. We use platelet rich plasma(PRP) contains several different growth factors that can stimulate nerve regeneration and prevent nerve adhesion. In this study, there were no differences about nerve adhesion between PRP administration or not, but nerve regeneration was superior in PRP administration group. (3) Clinical research for patients have peripheral nerve gap continue in this study. We developed a new nerve lengthening device for birth palsy.
|